Funding Rounds
Resalis Therapeutics

Resalis Therapeutics Series A (2024, $10M)

Resalis Therapeutics

Non-coding RNA-based therapeutics.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $10.92M

Raised Date: 2024-04-01

Investors